Influenza News and Research

Latest Influenza News and Research

Should stocks of smallpox virus be destroyed?

Smallpox was eradicated in 1980, but the virus still exists in WHO controlled depositories. In this week's BMJ , two experts go head to head over whether these stocks should be destroyed.

15 Apr 2007

Understanding of primate evolution advanced

The completed DNA sequence of the rhesus macaque ,an Old World monkey, has advanced understanding of primate evolution and will enhance medical research in neuroscience, behavioral biology, reproductive physiology, endocrinology, heart and blood vessel disease and immunodeficiency, said scientists at the Baylor College of Medicine (BCM) Human Genome Sequencing Center who led the effort.

15 Apr 2007

BioForce Nanosciences pursues support for ViriChip platform

BioForce Nanosciences continues their effort to fund development of the ViriChip platform, a patented system designed to rapidly and nondestructively detect and identify whole viruses.

12 Apr 2007

Experimental flu vaccine produced using insect cells shows promise

An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.

11 Apr 2007

Study shows beneficial effects of pneumococcal conjugate vaccines in children

Routine infant immunisation with pneumococcal conjugate vaccine (PCV7) has caused a 39% fall in all-cause pneumonia hospital admission rates for American children aged under two years, according to an Article published in this week's edition of The Lancet.

8 Apr 2007

Weak immune response critical to disease that causes most infant hospitalizations

The most common cause of infant hospitalization in the United States, respiratory syncytial virus, infects virtually all children by age two.

7 Apr 2007

Cylindrical nanoparticles deliver drugs to tumors

Researchers at the University of Pennsylvania School of Medicine & School of Engineering and Applied Science have discovered a better way to deliver drugs to tumors.

7 Apr 2007

Beneficial effects of pneumococcal conjugate vaccines in children re-emphasized

Routine infant immunization with pneumococcal conjugate vaccine (PCV7) has caused a 39 percent fall in all-cause pneumonia hospital admission rates for American children under 2, according to an article published in this week's edition of The Lancet .

7 Apr 2007

St. Jude Children's Research Hospital designated as Center of Excellence for Influenza Research and Surveillance

St. Jude Children's Research Hospital has been designated one of six Centers of Excellence for Influenza Research and Surveillance funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health.

4 Apr 2007

Primary lesson of the 1918 influenza pandemic is that it is critical to intervene early

One of the persistent riddles of the deadly 1918 Spanish influenza pandemic is why it struck different cities with varying severity.

4 Apr 2007

Inhaled corticosteroids deserve further consideration for lung cancer chemoprevention

Among a group of mostly older male veterans suffering from chronic obstructive pulmonary disease (COPD), an illness that offers a greater susceptibility to lung cancer, researchers found that regular use of high dose inhaled corticosteroids (ICS) lowered the risk of developing lung cancer.

4 Apr 2007

Surveillance for emergence of neuraminidase inhibitor resistant influenza viruses critically important

Use of certain common antiviral drugs during a recent influenza B epidemic in Japan showed the development of viruses with partial resistance to the drugs, according to a study in the April 4 issue of JAMA.

4 Apr 2007

CSL Biotherapies submits Biologics License Application to FDA

Pending approval of that application, CSL Biotherapies will introduce its influenza vaccine to the U.S. marketplace. The company's BLA requests that the vaccine be approved to immunize people 18 years of age and older.

3 Apr 2007

Emerging threats demand new approach to disaster preparedness

The SARS epidemic, the South Asian tsunami, Hurricane Katrina, and avian influenza all underline a growing need for preparedness planning that addresses multiple hazards and coordinates all levels of government and society, said a panel of public health experts today at the Pan American Health Organization (PAHO) in Washington, D.C.

3 Apr 2007

Six centers of excellence for influenza research and surveillance established in U.S.

The National Institute of Allergy and Infectious Diseases (NIAID) has announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.

2 Apr 2007

How does the highly pathogenic bird flu virus spread to new countries?

Might the domestic bird trade be responsible? Or is it wildfowl? Since last year, a team from CIRAD has been working on wildfowl. To date, the virus has not been detected in healthy wild birds, but many dead or dying birds have been found near infection foci.

2 Apr 2007

USAID strengthens fight against avian influenza globally

The U.S. Government through the U.S. Agency for International Development (USAID) announced a one- year, $19 million project to provide critical commodities to fight avian influenza.

2 Apr 2007

MedImmune licenses reverse genetics technology to sanofi pasteur

MedImmune has announced that it has licensed its proprietary reverse genetics intellectual property to sanofi pasteur, the vaccines business of the sanofi-aventis Group, to support the development and construction of new vaccine strains to produce human seasonal, pre-pandemic and pandemic influenza vaccines.

1 Apr 2007

Progress towards better access to pandemic influenza vaccines for developing countries

The World Health Organization (WHO) is reporting progress towards ensuring access to pandemic influenza vaccines for developing countries in the event of a pandemic and other vaccine-related aspects of influenza pandemic preparedness.

25 Mar 2007

Viral protein is an effective preventative against infection

For parents, eight million cases of acute middle-ear infections every year adds up to a lot of sleepless nights and trips to the pediatrician.

25 Mar 2007

Influenza News and Research

Latest Influenza News and Research

Should stocks of smallpox virus be destroyed?

Understanding of primate evolution advanced

BioForce Nanosciences pursues support for ViriChip platform

Experimental flu vaccine produced using insect cells shows promise

Study shows beneficial effects of pneumococcal conjugate vaccines in children

Weak immune response critical to disease that causes most infant hospitalizations

Cylindrical nanoparticles deliver drugs to tumors

Beneficial effects of pneumococcal conjugate vaccines in children re-emphasized

St. Jude Children's Research Hospital designated as Center of Excellence for Influenza Research and Surveillance

Primary lesson of the 1918 influenza pandemic is that it is critical to intervene early

Inhaled corticosteroids deserve further consideration for lung cancer chemoprevention

Surveillance for emergence of neuraminidase inhibitor resistant influenza viruses critically important

CSL Biotherapies submits Biologics License Application to FDA

Emerging threats demand new approach to disaster preparedness

Six centers of excellence for influenza research and surveillance established in U.S.

How does the highly pathogenic bird flu virus spread to new countries?

USAID strengthens fight against avian influenza globally

MedImmune licenses reverse genetics technology to sanofi pasteur

Progress towards better access to pandemic influenza vaccines for developing countries

Viral protein is an effective preventative against infection

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Influenza News and Research

Latest Influenza News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in